Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of ...

上述结果表明，作为Illumina测序系统中的“新贵”，NovaSeq平台不仅能获得和MiSeq平台高度一致的菌群组成结构，而且在测序质量上，也相比Q30>75%的MiSeq、NovaSeq PE250模式官方质控标准，有大幅提升！更重要的是，在NovaSeq平台上，能轻而易举的实现大样品量、高测序 ...

A central focus for Illumina has been the transition to its NovaSeq X platform, which promises to reduce sequencing costs by approximately threefold. This transition, however, has not been without ...

e公司讯，11月6日，在第七届中国国际进口博览会上，贝瑞基因与全球基因测序仪巨头因美纳（Illumina ... 型高通量测序仪NovaSeq™ X Plus项目。

Technologic advancements in sequencing by synthesis (SBS) chemistry and bioinformatics, together with long-read sequencing assays that can deliver contiguous data up to 10Kb, expand the breadth of ...

Welcome to a new era for clinical labs. The NovaSeq ™ 6000Dx is Illumina's first IVD high-throughput sequencing instrument for the clinical lab. Push the boundaries of clinical genomics with ...

This dichotomy in performance across different product lines highlights the complex market dynamics Illumina is navigating. A central focus for Illumina has been the transition to its NovaSeq X ...

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

Propel your research forward to impact the world, not the environment. The NovaSeq X and NovaSeq X Plus systems were purpose-designed to be our most sustainable sequencing systems with reductions ...

Sequencing giant Illumina Inc. ILMN is set to release third-quarter 2024 results on Nov. 4 after the closing bell. Stay up-to ...